Nymox Reports Positive Safety Monitoring Committee Results For Pivotal Phase 3 Trials

Nymox Reports Positive Safety Monitoring Committee Results For Pivotal Phase 3 Trials

[at noodls] – 800-93NYMOX For Further Information Contact: Roy Wolvin Nymox Pharmaceutical Corporation 1-800-93NYMOX www.nymox.com For Immediate Release: NEWS RELEASE Nymox Reports Positive Safety Monitoring Committee … more

View todays social media effects on NYMX

View the latest stocks trending across Twitter. Click to view dashboard

Share this post